SAN FRANCISCO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- A new securities class-action lawsuit has been filed against SelectQuote, Inc. (NYSE: SLQT) and its executives after the U.S. Department of Justice (DOJ) announced its intervention in a separate lawsuit against the company. This federal involvement triggered a sharp 19% decline in SelectQuote’s stock price on May 1, 2025, leading to significant investor losses. The lawsuit, known as Pahlkotter v. SelectQuote, Inc. et al., is on behalf of investors who purchas ...

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lockheed Martin Corporation (NYSE: LMT) between January 23, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 26, 2025 lead plaintiff deadline. SO WHAT: If you purchased Lockheed Martin securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired C3.ai, Inc. (“C3.ai” or the “Company”) (NYSE: AI) between February 26, 2025 and August 8, 2025, inclusive (the “Class Period”). The Complaint alleges that Defendants created the false impression that they possessed reliable infor ...

NEW YORK, Aug. 25, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2025.So what: If you purchased Nutex securities during the Class Period ...

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Charter, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/charter-communications-inc-class-action-lawsuit. Investors have until October 14, 2025, to ask ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Flywire Corporation securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Flywire securities between February 28, 2024, and February 25, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 23, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Flywire's management made false and misleading statements regarding the sustainability of its revenue growth and understated the negative impacts of permit and visa-related restrictions on its business [5]. - The claims suggest that these misrepresentations led to investor damages when the true information became public [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Centene Corporation securities between December 12, 2024, and June 30, 2025, of the September 8, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Centene securities during the specified class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the court by September 8, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that Centene's management provided misleading information regarding the company's revenue guidance and earnings per share for the 2025 fiscal year, while concealing adverse facts about enrollment and morbidity rates [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3].

Core Viewpoint - A lawsuit has been filed against Charter Communications, Inc. and certain senior executives for potential violations of federal securities laws, particularly related to the impact of the Affordable Connectivity Program's termination on the company's customer base and earnings [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Sandoval v. Charter Communications, Inc., No. 1:25-cv-06747, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until October 14, 2025, to request to be appointed to lead the case [2]. Group 2: Company Background - Charter Communications is a leading broadband and cable operator that participated in the FCC's Affordable Connectivity Program, which subsidized high-speed internet plans for low-income households [3]. - The Affordable Connectivity Program ended in June 2024 due to a lack of federal funding, leading to a decline in customers for Charter [3]. Group 3: Financial Impact - Charter claimed to have successfully managed the end of the Affordable Connectivity Program, stating that the impact was behind them; however, the company continued to experience declines in internet customers and revenue [4]. - In the second quarter of 2025, Charter reported a decrease of 117,000 total internet customers, including approximately 50,000 disconnects related to the end of the program, nearly double the disconnects from the previous quarter [5]. - Following the announcement of these results, Charter's stock price fell by $70.25 per share, or 18.4%, from $380.00 on July 24, 2025, to $309.75 on July 25, 2025 [5].

NEW YORK, Aug. 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/lineage-inc-class-action-lawsuit. Investors have until September 30, 2025, to ask the Court to b ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Novo Nordisk A/S securities between May 7, 2025, and July 28, 2025, of the September 30, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Novo Nordisk securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by September 30, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that defendants made misleading statements about Novo Nordisk's growth potential while concealing material adverse facts [4] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [3] Group 3: Case Allegations - The lawsuit claims that Novo Nordisk overstated its growth potential and the likelihood of patients switching to its branded alternatives, leading to investor damages when the true information became public [4]